Clinical Trial Update: Provoked Craving Relief Study by NRT [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by GlaxoSmithKline evaluated nicotine replacement therapy (NRT) for provoked craving relief in individuals seeking smoking cessation; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Nicotine replacement therapy (NRT) (nicotine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2013-09-30